Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P M Stokkel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 25, 2006
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literatureM P M Stokkel, C S J Duchateau, C Dragoiescu
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|November 2, 2002
Personal dosimetry of the staff during treatment of neuroendocrine tumours with a high dose of Indium-111 OctreotideM P M Stokkel, I N Boot, J W Smit
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 26, 2009
Transient ischemic dilatation ratio derived from myocardial perfusion scintigraphy: What are we looking at?B J van der Veen, N Kuperij, M P M Stokkel
Acta Paediatrica (Oslo, Norway : 1992)|October 27, 2004
Intractable congenital chylous ascitesA B te Pas, K vd Ven, M P M Stokkel, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancerA Ugrinska, E Bombardieri, M P M Stokkel, et al.
Nuklearmedizin. Nuclear Medicine|April 23, 2009
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131IF A Verburg, R B T Verkooijen, M P M Stokkel, et al.
European Journal of Endocrinology|August 13, 2009
Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysisA de Rooij, J P Vandenbroucke, J W A Smit, et al.
Plos One|February 2, 2021
Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest studyJ Olde Heuvel, B J de Wit-van der Veen, M Sinaasappel, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcomaM P M Stokkel, M F G Linthorst, J J J Borm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphyF A Dorkoosh, M P M Stokkel, D Blok, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 25, 2006
The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literatureM P M Stokkel, C S J Duchateau, C Dragoiescu
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|November 2, 2002
Personal dosimetry of the staff during treatment of neuroendocrine tumours with a high dose of Indium-111 OctreotideM P M Stokkel, I N Boot, J W Smit
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 26, 2009
Transient ischemic dilatation ratio derived from myocardial perfusion scintigraphy: What are we looking at?B J van der Veen, N Kuperij, M P M Stokkel
Acta Paediatrica (Oslo, Norway : 1992)|October 27, 2004
Intractable congenital chylous ascitesA B te Pas, K vd Ven, M P M Stokkel, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancerA Ugrinska, E Bombardieri, M P M Stokkel, et al.
Nuklearmedizin. Nuclear Medicine|April 23, 2009
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131IF A Verburg, R B T Verkooijen, M P M Stokkel, et al.
European Journal of Endocrinology|August 13, 2009
Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysisA de Rooij, J P Vandenbroucke, J W A Smit, et al.
Plos One|February 2, 2021
Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest studyJ Olde Heuvel, B J de Wit-van der Veen, M Sinaasappel, et al.
Journal of Cancer Research and Clinical Oncology|July 24, 2002
A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcomaM P M Stokkel, M F G Linthorst, J J J Borm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 24, 2004
Feasibility study on the retention of superporous hydrogel composite polymer in the intestinal tract of man using scintigraphyF A Dorkoosh, M P M Stokkel, D Blok, et al.
Pageof 3